Hepatotoxicity associated with carvedilol

Annals of Pharmacotherapy

Volumn 35, Issue 11, 2001, Pages 1364-1366

  Hagmeyer, K O ^a   Stein, J ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

Carvedilol; Hepatotoxicity

Indexed keywords

AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; HYDROXYZINE; METOPROLOL;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CARDIOMYOPATHY; CASE REPORT; DISEASE SEVERITY; DRUG WITHDRAWAL; HUMAN; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PRURITUS;

EID: 0034766057     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10239     Document Type: Article

References (10)

1. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease
2. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
3. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure
4. Effects of short-term and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity, and clinical conditions in patients with idiopathic dilated cardiomyopathy
5. Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind, randomized study
6. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
7. The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency
8. A method for estimating the probability of adverse drug reactions